Why GE HealthCare’s FDA-cleared SIGNA MRI update is more about operations than image quality
GE HealthCare’s FDA-cleared SIGNA MRI systems signal a shift toward autonomous, helium-free imaging. Explore what this means for MRI operations.
Next-generation SIGNA MRI gains FDA nod, sharpening GE HealthCare’s imaging strategy
GE HealthCare secures FDA clearance for next-generation SIGNA MRI. Explore clinical impact, workflow gains, and market implications.
What GE HealthCare’s $35m BARDA expansion reveals about the future of trauma imaging
GE HealthCare expands its BARDA-backed artificial intelligence ultrasound program. Discover what this changes for trauma care and emergency preparedness.